plumbagin has been researched along with Cardiotoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali Alharbi, S; Chinnathambi, A; Li, Z; Yin, F | 1 |
1 other study(ies) available for plumbagin and Cardiotoxicity
| Article | Year |
|---|---|
Plumbagin protects the myocardial damage by modulating the cardiac biomarkers, antioxidants, and apoptosis signaling in the doxorubicin-induced cardiotoxicity in rats.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Cardiotoxicity; Cytokines; Doxorubicin; Heart; Lipid Peroxidation; Male; Myocardium; Naphthoquinones; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Signal Transduction | 2020 |